rs141133579

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002857.4(PEX19):​c.771+3A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00554 in 1,613,042 control chromosomes in the GnomAD database, including 34 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0041 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0057 ( 29 hom. )

Consequence

PEX19
NM_002857.4 splice_region, intron

Scores

2
Splicing: ADA: 0.0002355
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.323

Publications

1 publications found
Variant links:
Genes affected
PEX19 (HGNC:9713): (peroxisomal biogenesis factor 19) This gene is necessary for early peroxisomal biogenesis. It acts both as a cytosolic chaperone and as an import receptor for peroxisomal membrane proteins (PMPs). Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. These disorders have at least 14 complementation groups, with more than one phenotype being observed for some complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of Zellweger syndrome (ZWS), as well as peroxisome biogenesis disorder complementation group 14 (PBD-CG14), which is also known as PBD-CGJ. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]
DCAF8-DT (HGNC:55792): (DCAF8 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 1-160280067-T-C is Benign according to our data. Variant chr1-160280067-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 282033.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00412 (627/152306) while in subpopulation NFE AF = 0.00562 (382/68006). AF 95% confidence interval is 0.00515. There are 5 homozygotes in GnomAd4. There are 331 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002857.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PEX19
NM_002857.4
MANE Select
c.771+3A>G
splice_region intron
N/ANP_002848.1A0A0S2Z497
PEX19
NM_001193644.1
c.771+3A>G
splice_region intron
N/ANP_001180573.1P40855
PEX19
NR_036492.2
n.670+3A>G
splice_region intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PEX19
ENST00000368072.10
TSL:1 MANE Select
c.771+3A>G
splice_region intron
N/AENSP00000357051.5P40855-1
ENSG00000258465
ENST00000485079.1
TSL:3
c.381+3A>G
splice_region intron
N/AENSP00000450870.1H0YJ60
PEX19
ENST00000472750.5
TSL:1
n.*538+3A>G
splice_region intron
N/AENSP00000434633.1P40855-6

Frequencies

GnomAD3 genomes
AF:
0.00412
AC:
627
AN:
152188
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00170
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00103
Gnomad FIN
AF:
0.0152
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00562
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00471
AC:
1182
AN:
250936
AF XY:
0.00491
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.00171
Gnomad ASJ exome
AF:
0.000893
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0152
Gnomad NFE exome
AF:
0.00623
Gnomad OTH exome
AF:
0.00490
GnomAD4 exome
AF:
0.00569
AC:
8313
AN:
1460736
Hom.:
29
Cov.:
32
AF XY:
0.00573
AC XY:
4162
AN XY:
726730
show subpopulations
African (AFR)
AF:
0.000837
AC:
28
AN:
33442
American (AMR)
AF:
0.00195
AC:
87
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00103
AC:
27
AN:
26130
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.00128
AC:
110
AN:
86224
European-Finnish (FIN)
AF:
0.0161
AC:
859
AN:
53414
Middle Eastern (MID)
AF:
0.000525
AC:
3
AN:
5712
European-Non Finnish (NFE)
AF:
0.00626
AC:
6951
AN:
1111056
Other (OTH)
AF:
0.00409
AC:
247
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
431
862
1293
1724
2155
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
256
512
768
1024
1280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00412
AC:
627
AN:
152306
Hom.:
5
Cov.:
32
AF XY:
0.00444
AC XY:
331
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.000962
AC:
40
AN:
41572
American (AMR)
AF:
0.00170
AC:
26
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4828
European-Finnish (FIN)
AF:
0.0152
AC:
161
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00562
AC:
382
AN:
68006
Other (OTH)
AF:
0.00521
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
33
66
99
132
165
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00486
Hom.:
2
Bravo
AF:
0.00327
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00502
EpiControl
AF:
0.00421

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Peroxisome biogenesis disorder 12A (Zellweger) (2)
-
-
1
not specified (1)
-
-
1
PEX19-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
9.1
DANN
Benign
0.59
PhyloP100
-0.32
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.8
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00024
dbscSNV1_RF
Benign
0.018
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141133579; hg19: chr1-160249857; API